Technical Analysis for ADMP - Adamis Pharmaceuticals Corporation

Grade Last Price % Change Price Change
grade D 2.88 0.00% 0.00
ADMP closed unchanged on Friday, January 18, 2019, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ADMP trend table...

Date Alert Name Type % Chg
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Above Upper BB Strength 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 MACD Bullish Centerline Cross Bullish 0.00%
Jan 17 Pocket Pivot Bullish Swing Setup 0.00%
Jan 17 Volume Surge Other 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Above Upper BB Strength 0.00%

Older signals for ADMP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Adamis Pharmaceuticals Corporation, a biopharmaceutical company, engages in the development and commercialization of specialty pharmaceutical products in the therapeutic areas of oncology, immunology and infectious diseases, and allergy and respiratory. The company focuses on the development of small molecule compounds, which comprise APC-100, APC-200, and APC-300 for the treatment of human prostate cancer; telomerase vaccine technologies; and other vaccine technologies for providing protection against various viral infectious agents. Its products under development also comprise TeloB-VAX, a novel cell-based vaccine product for prostate cancer; and Savvy(C31G), a contraceptive gel. The company's allergy and respiratory product pipeline includes Epinephrine Injection USP 1, a pre-filled single dose syringe product for use in the emergency treatment of extreme acute allergic reactions or anaphylactic shock; APC-1000, a steroid hydrofluoroalkane (HFA) metered dose inhaler product for asthma and chronic obstructive pulmonary disease; APC-2000, a generic HFA bronchodilator; and APC-3000, an HFA pressurized metered dose nasal steroid for the treatment of seasonal and perennial allergic rhinitis. It has a strategic manufacturing, supply, and product development agreement with Beximco Pharmaceuticals Ltd. The company is based in San Diego, California.
Is ADMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 5.1
52 Week Low 2.01
Average Volume 427,692
200-Day Moving Average 3.2661
50-Day Moving Average 2.598
20-Day Moving Average 2.427
10-Day Moving Average 2.585
Average True Range 0.1751
ADX 17.0
+DI 28.4571
-DI 13.0
Chandelier Exit (Long, 3 ATRs ) 2.4247
Chandelier Exit (Short, 3 ATRs ) 2.5353
Upper Bollinger Band 2.8424
Lower Bollinger Band 2.0116
Percent B (%b) 1.05
BandWidth 34.231562
MACD Line 0.0417
MACD Signal Line -0.026
MACD Histogram 0.0677
Fundamentals Value
Market Cap 90.29 Million
Num Shares 31.4 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -3.31
Price-to-Sales 14.86
Price-to-Book 4.42
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.09
Resistance 3 (R3) 3.09 3.02 3.06
Resistance 2 (R2) 3.02 2.97 3.02 3.04
Resistance 1 (R1) 2.95 2.93 2.92 2.95 3.03
Pivot Point 2.88 2.88 2.86 2.88 2.88
Support 1 (S1) 2.81 2.83 2.78 2.81 2.73
Support 2 (S2) 2.74 2.79 2.74 2.72
Support 3 (S3) 2.67 2.74 2.71
Support 4 (S4) 2.67